Ahead of the Launch Event: A Brief Look at Putting "Patient-Centricity" into Practice in Clinical Trials

Source: EClinCloud. Author: EClinCloud.
The core purpose of new drug R&D is to address patients' needs. Patients' actual experiences and real needs bring unique and valuable perspectives to drug development. These perspectives help improve the quality, relevance, safety, and efficiency of drug development and inform regulatory decision-making.
How to Achieve "Patient-Centricity"
"Patient-centricity" may seem like a simple phrase, yet it is easier said than done. Undeniably, many challenges remain in collecting and applying real-world evidence, involving issues such as patient privacy, data formatting, and data security; from data capture to data quality and standardization, everything is still in an exploratory stage.
In recent years, however, patient-centric clinical trials for drug development have been shifting toward digitalization, adopting methodologically sounder tools to identify, collect, and analyze patient data so as to obtain clinical outcomes as objectively and comprehensively as possible in clinical research. In addition, policies introduced to better protect patients' medication rights and interests—such as the "4+7" volume-based procurement, consistency evaluation, and DRG-based medical insurance cost control—have placed higher demands on the R&D efficiency of innovative drug developers, further compelling pharmaceutical companies to pursue digital transformation in clinical research.
On the premise of safeguarding patient safety and ensuring data quality and study continuity, reducing subject burden in a safe, convenient, and rapid manner is an essential path for pharmaceutical companies and sponsors to achieve "patient-centricity."
How Do Pharmaceutical Companies Interpret "Patient-Centricity"?
One well-known pharmaceutical company defines it as: "Practicing 'patients first' through open and ongoing communication, and acting with sincerity and care to achieve the best treatment outcomes and experiences for patients and their families."
Another well-known pharmaceutical company has established a decision-making framework in which patient-centric options are given priority. The company's national sales head noted that this framework can be summarized in four words—patients, trust, reputation, and business—and that whenever an important decision has to be made or a strategic option chosen, patients are considered first.
EClinCloud's Products Will Assist Sponsors in
Continuously Deepening "Patient-Centricity" in Clinical Trials
In June 2020, the U.S. FDA issued the guidance for industry "Patient-Focused Drug Development: Collecting Comprehensive and Representative Input," aimed at guiding investigators, product developers, and other stakeholders on how to collect and submit comprehensive and representative patient input for medical product development and regulatory decision-making.
Guided by technological innovation and precision medicine evaluation standards, EClinCloud's "patient-centric" and "data-driven" integrated clinical evidence support SaaS platform can genuinely improve pharmaceutical companies' clinical research efficiency.
EClinCloud Product Launch Event
On July 17, EClinCloud will hold its "Digital Breakthrough: Ascending Together with EClinCloud" integrated clinical trial cloud platform launch event. EClinCloud CEO Qin Long will deliver a keynote speech at the event to explain how the integrated cloud platform puts patients at the center and addresses pain points in clinical trials. (Registration details are noted at the bottom of the image below; EClinCloud looks forward to your attendance.)
Event Date: July 17, 2022
Event Venue: Shangri-La Qiantan, Shanghai

About EClinCloud
EClinCloud is a healthcare and life-sciences technology company rooted in China and serving the world. Guided by its mission of "Bringing Effective Treatments to Patients Through Technological Innovation" and driven by science and medicine, it combines digital technology with life-sciences data to build an end-to-end digital clinical trial cloud platform and provide technical solutions for clinical endpoint assessment, helping domestic and international pharmaceutical companies and research institutions improve R&D efficiency, accelerate the market launch of drugs and medical devices, and benefit countless patients.



